Showing results (1-10 of 222) with videos related to
Sort By:
Pageof 23
Current Opinion in Genetics & Development|April 8, 2019
Dissecting PARP inhibitor resistance with functional genomicsStephen J Pettitt, Christopher J LordCancer Treatment and Research|November 17, 2023
Exploiting Cancer Synthetic Lethality in Cancer-Lessons Learnt from PARP InhibitorsStephen J Pettitt, Colm J Ryan, Christopher J LordMolecular Oncology|May 14, 2022
Resistance to DNA repair inhibitors in cancerJoseph S Baxter, Diana Zatreanu, Stephen J Pettitt, et al.Nature Genetics|November 30, 2023
Complex synthetic lethality in cancerColm J Ryan, Lovely Paul Solomon Devakumar, Stephen J Pettitt, et al.Molecular Cell|July 6, 2022
Captured snapshots of PARP1 in the active state reveal the mechanics of PARP1 allosteryÉlise Rouleau-Turcotte, Dragomir B Krastev, Stephen J Pettitt, et al.Open Biology|July 27, 2022
Opinion: PARP inhibitors in cancer-what do we still need to know?Andrew J Wicks, Dragomir B Krastev, Stephen J Pettitt, et al.The Journal of Pathology. Clinical Research|October 3, 2019
Longitudinal analysis of a secondary BRCA2 mutation using digital droplet PCRSaira Khalique, Stephen J Pettitt, Ger Kelly, et al.Oncogene|June 20, 2018
Identification of highly penetrant Rb-related synthetic lethal interactions in triple negative breast cancerRachel Brough, Aditi Gulati, Syed Haider, et al.Nature Communications|May 24, 2018
Coupling bimolecular PARylation biosensors with genetic screens to identify PARylation targetsDragomir B Krastev, Stephen J Pettitt, James Campbell, et al.Nature Genetics|March 3, 2025
The transcriptomic architecture of common cancers reflects synthetic lethal interactionsSyed Haider, Rachel Brough, Santiago Madera, et al.Pageof 23